Peanut allergy cured in 70% children in immunotherapy trial
An Australia-based clinical trial has reported long-lasting effects of peanut allergy treatment in 70% of the children participating in immunotherapy. The peanut tolerance persisted for up to four years after the treatment. Peanut allergy is the most common cause of anaphylaxis, a life-threatening allergic reaction and one of the most common causes of death from food allergy, researchers said.